SELLAS Life Sciences Group, Inc. (SLS)
7.08
-0.34
(-4.58%)
USD |
NASDAQ |
May 15, 16:00
7.13
+0.05
(+0.71%)
After-Hours: 20:00
SELLAS Life Sciences Group EPS Diluted (Quarterly) : -0.0487 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rezolute, Inc. | -0.1554 |
| Krystal Biotech, Inc. | 1.833 |
| Spero Therapeutics, Inc. | -0.1258 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
| Whitehawk Therapeutics, Inc. | -0.3206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.407M |
| Total Expenses (Quarterly) | 8.407M |
| Enterprise Value | 1.211B |
| Earnings Yield | -3.22% |
| Normalized Earnings Yield | -3.226 |